The rewards of nicotine: Regulation by tissue plasminogen activator-plasmin system through protease activated receptor-1

Taku Nagai, Mina Ito, Noritaka Nakamichi, Hiroyuki Mizoguchi, Hiroyuki Kamei, Ayumi Fukakusa, Toshitaka Nabeshima, Kazuhiro Takuma, Kiyofumi Yamada

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Nicotine, a primary component of tobacco, is one of the most abused drugs worldwide. Approximately four million people die each year because of diseases associated with tobacco smoking. Mesolimbic dopaminergic neurons mediate the rewarding effects of abused drugs, including nicotine. Here we show that the tissue plasminogen activator (tPA)-plasmin system regulates nicotine-induced reward and dopamine release by activating protease activated receptor-1 (PAR1). In vivo microdialysis revealed that microinjection of either tPA or plasmin into the nucleus accumbens (NAc) significantly potentiated whereas plasminogen activator inhibitor-1 reduced the nicotineinduced dopamine release in the NAc in a dose-dependent manner. Nicotine-induced dopamine release was markedly diminished in tPA-deficient (tPA-/-)mice, and the defect of dopamine release in tPA-/- mice was restored by microinjection of either exogenous tPA or plasmin into the NAc. Nicotine increased tPA protein levels and promoted the release of tPA into the extracellular space in the NAc. Immunohistochemistry revealed that PAR1 immunoreactivity was localized to the nerve terminals positive for tyrosine hydroxylase in the NAc. Furthermore, we demonstrated that plasmin activated PAR1 and that nicotine-induced place preference and dopamine release were diminished in PAR1-deficient (PAR1 -/-) mice. Targeting the tPA-plasmin-PAR1 system would provide new therapeutic approaches to the treatment of nicotine dependence.

Original languageEnglish
Pages (from-to)12374-12383
Number of pages10
JournalJournal of Neuroscience
Volume26
Issue number47
DOIs
Publication statusPublished - 22-11-2006

Fingerprint

PAR-1 Receptor
Fibrinolysin
Tissue Plasminogen Activator
Nicotine
Reward
Nucleus Accumbens
Dopamine
Microinjections
Tobacco Use Disorder
Dopaminergic Neurons
Plasminogen Activator Inhibitor 1
Microdialysis
Extracellular Space
Tyrosine 3-Monooxygenase
Pharmaceutical Preparations
Tobacco
Smoking
Immunohistochemistry

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)

Cite this

Nagai, Taku ; Ito, Mina ; Nakamichi, Noritaka ; Mizoguchi, Hiroyuki ; Kamei, Hiroyuki ; Fukakusa, Ayumi ; Nabeshima, Toshitaka ; Takuma, Kazuhiro ; Yamada, Kiyofumi. / The rewards of nicotine : Regulation by tissue plasminogen activator-plasmin system through protease activated receptor-1. In: Journal of Neuroscience. 2006 ; Vol. 26, No. 47. pp. 12374-12383.
@article{0937971728ec4b259ed4272f6e58433f,
title = "The rewards of nicotine: Regulation by tissue plasminogen activator-plasmin system through protease activated receptor-1",
abstract = "Nicotine, a primary component of tobacco, is one of the most abused drugs worldwide. Approximately four million people die each year because of diseases associated with tobacco smoking. Mesolimbic dopaminergic neurons mediate the rewarding effects of abused drugs, including nicotine. Here we show that the tissue plasminogen activator (tPA)-plasmin system regulates nicotine-induced reward and dopamine release by activating protease activated receptor-1 (PAR1). In vivo microdialysis revealed that microinjection of either tPA or plasmin into the nucleus accumbens (NAc) significantly potentiated whereas plasminogen activator inhibitor-1 reduced the nicotineinduced dopamine release in the NAc in a dose-dependent manner. Nicotine-induced dopamine release was markedly diminished in tPA-deficient (tPA-/-)mice, and the defect of dopamine release in tPA-/- mice was restored by microinjection of either exogenous tPA or plasmin into the NAc. Nicotine increased tPA protein levels and promoted the release of tPA into the extracellular space in the NAc. Immunohistochemistry revealed that PAR1 immunoreactivity was localized to the nerve terminals positive for tyrosine hydroxylase in the NAc. Furthermore, we demonstrated that plasmin activated PAR1 and that nicotine-induced place preference and dopamine release were diminished in PAR1-deficient (PAR1 -/-) mice. Targeting the tPA-plasmin-PAR1 system would provide new therapeutic approaches to the treatment of nicotine dependence.",
author = "Taku Nagai and Mina Ito and Noritaka Nakamichi and Hiroyuki Mizoguchi and Hiroyuki Kamei and Ayumi Fukakusa and Toshitaka Nabeshima and Kazuhiro Takuma and Kiyofumi Yamada",
year = "2006",
month = "11",
day = "22",
doi = "10.1523/JNEUROSCI.3139-06.2006",
language = "English",
volume = "26",
pages = "12374--12383",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "47",

}

Nagai, T, Ito, M, Nakamichi, N, Mizoguchi, H, Kamei, H, Fukakusa, A, Nabeshima, T, Takuma, K & Yamada, K 2006, 'The rewards of nicotine: Regulation by tissue plasminogen activator-plasmin system through protease activated receptor-1', Journal of Neuroscience, vol. 26, no. 47, pp. 12374-12383. https://doi.org/10.1523/JNEUROSCI.3139-06.2006

The rewards of nicotine : Regulation by tissue plasminogen activator-plasmin system through protease activated receptor-1. / Nagai, Taku; Ito, Mina; Nakamichi, Noritaka; Mizoguchi, Hiroyuki; Kamei, Hiroyuki; Fukakusa, Ayumi; Nabeshima, Toshitaka; Takuma, Kazuhiro; Yamada, Kiyofumi.

In: Journal of Neuroscience, Vol. 26, No. 47, 22.11.2006, p. 12374-12383.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The rewards of nicotine

T2 - Regulation by tissue plasminogen activator-plasmin system through protease activated receptor-1

AU - Nagai, Taku

AU - Ito, Mina

AU - Nakamichi, Noritaka

AU - Mizoguchi, Hiroyuki

AU - Kamei, Hiroyuki

AU - Fukakusa, Ayumi

AU - Nabeshima, Toshitaka

AU - Takuma, Kazuhiro

AU - Yamada, Kiyofumi

PY - 2006/11/22

Y1 - 2006/11/22

N2 - Nicotine, a primary component of tobacco, is one of the most abused drugs worldwide. Approximately four million people die each year because of diseases associated with tobacco smoking. Mesolimbic dopaminergic neurons mediate the rewarding effects of abused drugs, including nicotine. Here we show that the tissue plasminogen activator (tPA)-plasmin system regulates nicotine-induced reward and dopamine release by activating protease activated receptor-1 (PAR1). In vivo microdialysis revealed that microinjection of either tPA or plasmin into the nucleus accumbens (NAc) significantly potentiated whereas plasminogen activator inhibitor-1 reduced the nicotineinduced dopamine release in the NAc in a dose-dependent manner. Nicotine-induced dopamine release was markedly diminished in tPA-deficient (tPA-/-)mice, and the defect of dopamine release in tPA-/- mice was restored by microinjection of either exogenous tPA or plasmin into the NAc. Nicotine increased tPA protein levels and promoted the release of tPA into the extracellular space in the NAc. Immunohistochemistry revealed that PAR1 immunoreactivity was localized to the nerve terminals positive for tyrosine hydroxylase in the NAc. Furthermore, we demonstrated that plasmin activated PAR1 and that nicotine-induced place preference and dopamine release were diminished in PAR1-deficient (PAR1 -/-) mice. Targeting the tPA-plasmin-PAR1 system would provide new therapeutic approaches to the treatment of nicotine dependence.

AB - Nicotine, a primary component of tobacco, is one of the most abused drugs worldwide. Approximately four million people die each year because of diseases associated with tobacco smoking. Mesolimbic dopaminergic neurons mediate the rewarding effects of abused drugs, including nicotine. Here we show that the tissue plasminogen activator (tPA)-plasmin system regulates nicotine-induced reward and dopamine release by activating protease activated receptor-1 (PAR1). In vivo microdialysis revealed that microinjection of either tPA or plasmin into the nucleus accumbens (NAc) significantly potentiated whereas plasminogen activator inhibitor-1 reduced the nicotineinduced dopamine release in the NAc in a dose-dependent manner. Nicotine-induced dopamine release was markedly diminished in tPA-deficient (tPA-/-)mice, and the defect of dopamine release in tPA-/- mice was restored by microinjection of either exogenous tPA or plasmin into the NAc. Nicotine increased tPA protein levels and promoted the release of tPA into the extracellular space in the NAc. Immunohistochemistry revealed that PAR1 immunoreactivity was localized to the nerve terminals positive for tyrosine hydroxylase in the NAc. Furthermore, we demonstrated that plasmin activated PAR1 and that nicotine-induced place preference and dopamine release were diminished in PAR1-deficient (PAR1 -/-) mice. Targeting the tPA-plasmin-PAR1 system would provide new therapeutic approaches to the treatment of nicotine dependence.

UR - http://www.scopus.com/inward/record.url?scp=33751311987&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33751311987&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.3139-06.2006

DO - 10.1523/JNEUROSCI.3139-06.2006

M3 - Article

C2 - 17122062

AN - SCOPUS:33751311987

VL - 26

SP - 12374

EP - 12383

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 47

ER -